These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 24666396)
21. [Non-melanoma skin cancer: incidence time trends analysis in Girona, Spain, 1994-2007]. Vilar-Coromina N; Miró-Queralt J; Cano-Bautista A; Vilardell-Gil L; Torres Babié P; Marcos-Gragera R Med Clin (Barc); 2011 Jul; 137(4):145-51. PubMed ID: 21601891 [TBL] [Abstract][Full Text] [Related]
22. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management. Tessari G; Girolomoni G Dermatol Surg; 2012 Oct; 38(10):1622-30. PubMed ID: 22805312 [TBL] [Abstract][Full Text] [Related]
23. A systematic review of worldwide incidence of nonmelanoma skin cancer. Lomas A; Leonardi-Bee J; Bath-Hextall F Br J Dermatol; 2012 May; 166(5):1069-80. PubMed ID: 22251204 [TBL] [Abstract][Full Text] [Related]
24. Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978-2012: empirical relationships. Xiang F; Lucas R; Hales S; Neale R JAMA Dermatol; 2014 Oct; 150(10):1063-71. PubMed ID: 25103031 [TBL] [Abstract][Full Text] [Related]
25. Demographic and tumor characteristics of patients diagnosed with nonmelanoma skin cancer: 13-year retrospective study. Mistry N; Abanto Z; Bajdik C; Rivers JK J Cutan Med Surg; 2012; 16(1):32-8. PubMed ID: 22417993 [TBL] [Abstract][Full Text] [Related]
26. Epidemiological and pathological aspects of skin cancer in North East of Romania. Andrese E; Solovăstru LG; Taranu T; Iancu LS Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):457-62. PubMed ID: 25076715 [TBL] [Abstract][Full Text] [Related]
27. Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer. Reinau D; Surber C; Jick SS; Meier CR Int J Cancer; 2015 Jul; 137(1):144-53. PubMed ID: 25418602 [TBL] [Abstract][Full Text] [Related]
28. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma. Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292 [TBL] [Abstract][Full Text] [Related]
29. Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution. Ng JC; Cumming S; Leung V; Chong AH Australas J Dermatol; 2014 Feb; 55(1):43-8. PubMed ID: 23808627 [TBL] [Abstract][Full Text] [Related]
30. Changing incidence of non-melanoma skin cancer in New Zealand. Brougham ND; Dennett ER; Tan ST ANZ J Surg; 2011 Sep; 81(9):633-6. PubMed ID: 22295395 [TBL] [Abstract][Full Text] [Related]
31. National incidence of eyelid cancer in Ireland (2005-2015). Quigley C; Deady S; Hughes E; McElnea E; Zgaga L; Chetty S Eye (Lond); 2019 Oct; 33(10):1534-1539. PubMed ID: 30976073 [TBL] [Abstract][Full Text] [Related]
32. Occupation and keratinocyte cancer risk: a population-based case-control study. Marehbian J; Colt JS; Baris D; Stewart P; Stukel TA; Spencer SK; Karagas MR Cancer Causes Control; 2007 Oct; 18(8):895-908. PubMed ID: 17638107 [TBL] [Abstract][Full Text] [Related]
33. Patterns and timing of sunlight exposure and risk of basal cell and squamous cell carcinomas of the skin--a case-control study. Iannacone MR; Wang W; Stockwell HG; O'Rourke K; Giuliano AR; Sondak VK; Messina JL; Roetzheim RG; Cherpelis BS; Fenske NA; Rollison DE BMC Cancer; 2012 Sep; 12():417. PubMed ID: 22994655 [TBL] [Abstract][Full Text] [Related]
34. Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight. Leiter U; Garbe C Adv Exp Med Biol; 2008; 624():89-103. PubMed ID: 18348450 [TBL] [Abstract][Full Text] [Related]
35. Trends during a half century in relative squamous cell carcinoma distribution by body site in the Swedish population: support for accumulated sun exposure as the main risk factor. Dal H; Boldemann C; Lindelöf B J Dermatol; 2008 Feb; 35(2):55-62. PubMed ID: 18271799 [TBL] [Abstract][Full Text] [Related]
36. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Peyrin-Biroulet L; Khosrotehrani K; Carrat F; Bouvier AM; Chevaux JB; Simon T; Carbonnel F; Colombel JF; Dupas JL; Godeberge P; Hugot JP; Lémann M; Nahon S; Sabaté JM; Tucat G; Beaugerie L; Gastroenterology; 2011 Nov; 141(5):1621-28.e1-5. PubMed ID: 21708105 [TBL] [Abstract][Full Text] [Related]
37. Epidemiology of basal cell carcinoma in Lithuania, 1996-2010. Jurciukonyte R; Vincerzevskiene I; Krilaviciute A; Bylaite M; Smailyte G Br J Dermatol; 2013 Nov; 169(5):1100-5. PubMed ID: 23795568 [TBL] [Abstract][Full Text] [Related]
38. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients. Mackenzie KA; Wells JE; Lynn KL; Simcock JW; Robinson BA; Roake JA; Currie MJ Nephrol Dial Transplant; 2010 Jan; 25(1):300-6. PubMed ID: 19783601 [TBL] [Abstract][Full Text] [Related]
39. Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers. Zaravinos A; Kanellou P; Spandidos DA Br J Dermatol; 2010 Feb; 162(2):325-31. PubMed ID: 19849697 [TBL] [Abstract][Full Text] [Related]
40. Incidence of Nonmelanoma Skin Cancers in Alberta, Canada, From 2007 to 2018. Chambers DB; Ghosh S; Taher MS; Salopek TG J Cutan Med Surg; 2024; 28(3):238-247. PubMed ID: 38374688 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]